Header image

Healing and dealing with atopic dermatitis

Saturday, August 3, 2024
11:30 AM - 12:10 PM
C2.2 + C2.3
Sponsored By:


Atopic dermatitis (AD), also known as eczema or atopic eczema, is a chronic, relapsing inflammatory skin condition characterised by redness, swelling, cracking and weeping. AD affects people of all age and racial groups across the globe. The prevalence of AD is increasing and interestingly the incidence of AD is higher in urbanised, western societies. AD affects 7% of the Australian population. Whilst AD commonly presents in children, it can affect individuals of any age. Individuals living with AD experience a range of psycho-social, physical and emotional challenges including a decreased quality of life and mental health disorders. Moreover, they may have a higher risk of developing a range of other physical and psychological co-morbidities including asthma, rhinitis, diabetes and cardiovascular conditions.

Pharmacists can support the management of AD, often being the initial point of contact for a patient. During this session we will explore effective management options for AD and the role of the pharmacist in supporting individuals with AD.

Learning objectives
At the end of this session, participants will be able to:
1. Outline the clinical features associated with atopic dermatitis.
2. Describe the effective management of atopic dermatitis.
3. Outline the role of pharmacists in the assessment, referral, and management of atopic dermatitis.
Competency standards: 1.3, 2.1, 3.1, 3.5, 3.6


Agenda Item Image
Bree Armstrong
Project Manager

Healing and Dealing with atopic dermatitis


Bree Armstrong has worked as a pharmacist across multiple practice settings including delivering HMRs and RMMRs since 2007, as an embedded pharmacist in general practice and as part of a multidisciplinary outreach hospital team. Bree has a special interest in providing quality use of medicine educational activities through her previous work with NPS MedicineWise and now as a project manager with The PSA.